Master authentic, confident speaking by understanding core values, adapting to your audience, and practicing spontaneity like an athlete, not by rote memorization.
Chronic emotional suppression fuels inflammation and "surprise diseases." Learn how hypervigilance, achievement focus, and emotional distance disrupt your health and how to build emotional immunity.
AI's resurgence began with ImageNet, a massive dataset proving data quality, not just quantity, drives breakthroughs. Now, AI is a civilizational force shaping our future.
Your mouth is the gateway to your whole body; optimize it with nasal breathing and whole foods to reduce inflammation, improve sleep, and boost systemic health.
"Protocols: An Operating Manual for the Human Body" by Andrew Huberman - This is the host's upcoming book, covering science-based tools for various aspects of health.
Videos & Documentaries
Ted talk by Dr. David Fajgenbaum - Mentioned as a way to learn more about his work and raise awareness.
Research & Studies
"Cell" paper on sleep deprivation in mice - This study showed that sleep deprivation led to cytokine storms and immune system overactivity in mice, potentially relevant to autoimmune flares.
Study on PD-L1 expression in angiosarcoma tumors - This 2013 paper found increased PD-L1 expression in angiosarcoma tumors, which later led to testing PD-1 inhibitors for the condition.
Tools & Software
AI Platform/Machine Learning Models - Used by Every Cure to quantify the likelihood of every drug treating every disease.
PubMed - A database used for searching scientific literature, mentioned as a resource for finding information on treatments.
Biomedical Knowledge Graphs - A concept used by Every Cure to map the world's knowledge of human biology.
Articles & Papers
Paper on Tnf Inhibitors and Dada2 - Mentioned as a case where a doctor treated a child with Dada2 using a Tnf inhibitor, leading to the child stopping having strokes.
Paper on PD-L1 expression in angiosarcoma tumors - This 2013 paper found increased PD-L1 expression in angiosarcoma tumors, which later led to testing PD-1 inhibitors for the condition.
People Mentioned
Dr. David Fajgenbaum - Guest on the podcast, professor of translational medicine and human genetics at the University of Pennsylvania, founder of Every Cure.
Dr. Benjamin Castleman - Physician after whom Castleman's disease is named.
Dr. Kazuhiro Yoshizaki - Discovered the drug Tocilizumab (Tocilizumab) for Castleman's disease in Japan.
Chip Chambers - Doctor who, after his children were born with Dada2, researched and helped bring Tnf inhibitors to treat the condition.
Dr. Luke Chen - A colleague of Dr. Fajgenbaum in hematology who brainstorms treatment options for patients.
Michael Easter - Author of "The Comfort Crisis," discussed in the context of voluntary hardship and gratitude.
Dr. Joe Parvizi - Neurosurgeon at Stanford who identified the role of the anterior mid-cingulate cortex in tenacity and leaning into challenges.
Chris McCarty - Researcher in Florida studying Kratom.
Organizations & Institutions
University of Pennsylvania - Where Dr. David Fajgenbaum is a professor.
Stanford School of Medicine - Where Andrew Huberman is a professor.
Georgetown University - Where Dr. Fajgenbaum was a freshman and played football.
Oxford University - Where Dr. Fajgenbaum completed a graduate degree.
Every Cure - A nonprofit organization founded by Dr. David Fajgenbaum to find new uses for existing drugs.
Castleman Disease Collaborative Network - A foundation started by Dr. Fajgenbaum to support Castleman's patients and research.
ALS Association - An example of a disease organization.
Michael J. Fox Foundation for Parkinson's Disease - An example of a disease organization.
Arpa H (Advanced Research Projects Agency for Health) - A US government agency that is a significant funder of Every Cure.
Environmental Working Group (EWG) - Referenced for studies on PFAST chemicals and cancer-causing chemicals in tap water.
UCSF (University of California, San Francisco) - Mentioned in the context of its Chair of Neurosurgery.
Courses & Educational Resources
Huberman Lab Podcast - The podcast itself is presented as a resource for science-based tools.
Huberman Lab Newsletter (Neural Network Newsletter) - A monthly newsletter offering podcast summaries and protocols.
Websites & Online Resources
everycure.org - The website for the nonprofit organization Every Cure.
everycure.org/ideas - The section of the Every Cure website where people can submit potential drug repurposing ideas.
everycure.org/experts - The section of the Every Cure website for experts to sign up.
everycure.org/donate - The donation page for Every Cure.
protocolsbook.com - The website for Andrew Huberman's book, "Protocols: An Operating Manual for the Human Body."
drinkagz.com/huberman - Website for AG1's new sleep product, AGZ.
eightsleep.com/huberman - Website for Eight Sleep mattress covers.
functionhealth.com/huberman - Website for Function health testing.
rora.com/huberman - Website for Rora water filters.
davidprotein.com/huberman - Website for David protein bars.
Other Resources
Aspirin - Discussed for its pain-relieving effects and potential benefits in offsetting heart attacks and reducing the risk of colon cancer recurrence.
Viagra (Sildenafil) - Mentioned as a drug repurposed from heart disease to treat erectile dysfunction and a rare pediatric lung disease.
Cialis (Tadalafil) - Mentioned as a cousin of Viagra, initially used for prostate health and later discovered to have other effects related to sexual function.
Lidocaine - Discussed as a numbing medicine that, when injected around a breast cancer tumor before surgery, showed a significant reduction in mortality at five years.
Lithium - Mentioned as a potential protectant for Alzheimer's or other forms of dementia, with some psychiatrists taking low doses.
Tnf inhibitors - Drugs that inhibit Tumor Necrosis Factor, mentioned in the context of treating Dada2 and Aladalimumab for Castleman's disease.
Tnf alpha - A cytokine involved in inflammatory response.
Dada2 - A rare genetic condition causing numerous strokes in children.
Tnf inhibitor - A type of drug that inhibits Tnf.
Tocilizumab (Tocilizumab) - A drug originally developed in Japan for Castleman's disease, later approved in the US for rheumatoid arthritis and other autoimmune diseases.
Adria mycin - A chemotherapy drug.
Taxotere - A chemotherapy drug.
Topotecan - A chemotherapy drug.
Velcade - A chemotherapy drug.
Xeloda - A chemotherapy drug.
Mycin - A chemotherapy drug (likely referring to a class of drugs).
Cyclosporine - An immunosuppressant drug, one of two Dr. Fajgenbaum tried for his relapse.
IvIg (Intravenous Immunoglobulin) - Another drug Dr. Fajgenbaum tried for his relapse.
Rapamycin (Sirolimus) - An mTOR inhibitor approved for organ transplant rejection, which Dr. Fajgenbaum has been taking for Castleman's disease.
mTOR pathway - A signaling pathway in the immune system.
Bachmann Bupp Syndrome - A rare condition where children have elevated levels of the enzyme OCE1, treatable with DFMO.
DFMO (Eflornithine) - A drug made for African sleeping sickness that can treat Bachmann Bupp Syndrome.
Colchicine - A drug typically used for gout, with evidence suggesting it can reduce the risk of heart attacks, particularly in individuals with prior heart attacks and diabetes.
Magnesium three and eight theanine - Supplements that can help with sleep.
Chamomile extract - A supplement that can help with sleep.
Saffron - A supplement that can help with sleep.
Valerian root - A supplement that can help with sleep.
AGZ - A nightly drink by AG1 designed to help with sleep.
David protein bars - Protein bars with high protein and low sugar.
Glialblastoma - A type of brain cancer.
Vascularitis - Inflammation of blood vessels.
Interleukin-6 (IL-6) - A cytokine involved in inflammation.
Poems Syndrome - A rare cancer similar to multiple myeloma.
Ruxolitinib - A drug used for myelofibrosis, found to be effective for Castleman's disease.
Melanoma - A type of skin cancer.
Pembrolizumab - A PD-1 inhibitor now used for dozens of cancers, initially developed for melanoma and lung cancer.
PD-1 inhibitor - A type of immunotherapy drug.
PDL1 - A marker that indicates a potential response to a PD-1 inhibitor.
Angiosarcoma - A type of cancer.
Open Evidence - A company attempting to create a GPT for healthcare.
Creatine - A supplement discussed for strength and potential cognitive support.
Nicorette - Nicotine gum used by a Nobel laureate neuroscientist for potential protection against Alzheimer's and Parkinson's.
GLP-1s (Glucagon-like peptide-1 receptor agonists) - Drugs that may offer benefits in reducing the risk of Parkinson's, Alzheimer's, and breast cancer.
Rapamycin (Sirolimus) - Found in soil samples from Rapa Nui (Easter Island), initially investigated as an antifungal, then for immunosuppression, and now used for organ transplant rejection and potentially longevity.
Kratom - A plant product sold as a natural opioid replacement, which can also be highly addictive.
Coca plant - Contains alkaloids being tested for pain relief and psychoactive properties.
Micona purines - A velvety bean that is 99% L-Dopa.